| 1 |
Maurer JR, Frost AE, Estenne M, et al. International guidelines for the selection of lungtransplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society[J]. J Heart Lung Transplant, 1998, 17(7): 703-709.
|
| 2 |
Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 2006, 25(7): 745-755.
|
| 3 |
Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014-an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 2015, 34(1): 1-15.
|
| 4 |
Yusen RD, Edwards LB, Dipchand AI, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; focus theme: primary diagnostic indications for transplant[J]. J Heart Lung Transplant, 2016, 35(10): 1170-1184.
|
| 5 |
Yusen RD, Christie JD, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report-2013; focus theme: age[J]. J Heart Lung Transplant, 2013, 32(10): 965-978.
|
| 6 |
Lahzami S, Bridevaux PO, Soccal PM, et al. Survival impact of lung transplantation for COPD[J]. Eur Respir J, 2010, 36(1): 74-80.
|
| 7 |
Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
|
| 8 |
Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2011, 183(4): 431-440.
|
| 9 |
Taylor DA, du Bois RM. Idiopathic interstitial pneumonias: a re-appraisal of idiopathic pulmonary fibrosis[J]. Int J Tuberc Lung Dis, 2001, 5(12): 1086-1098.
|
| 10 |
Michaelson JE, Aguayo SM, Roman J. Idiopathic pulmonary fibrosis: a practical approach for diagnosis and management[J]. Chest, 2000, 118(3): 788-794.
|
| 11 |
Selman M, King TE, Pardo A; American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevaling and evolving hypotheses about its pathogenesis and implications for therapy[J]. Ann Intern Med, 2001, 134(2): 136-151.
|
| 12 |
Noble PW. Idiopathic pulmonary fibrosis: natural history and prognosis[J]. Clin Chest Med, 2006, 27(1 Suppl 1): S11-S16.
|
| 13 |
Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010[J]. J Heart Lung Transplant, 2010, 29(10): 1104-1118.
|
| 14 |
Takagishi T, Ostrowsik R, Alex C, et al. Survival and extrapulmonary course of connective tissue disease after lung transplantation[J]. J Clin Rheumatol, 2012, 18(6): 283-289.
|
| 15 |
Showkat A, Lo A, Shokouh-Amiri H, et al. Are autoimmune disease of glomerulonephritis affecting the development of panel-reactive antibodies in candidates for renal transplantation？[J]. Transplant Proc, 2005, 37(2): 645-647.
|
| 16 |
Banham G, Prezzi D, Harford S, et al. Elevated pretansplantation soluble BAFF is associated with an increased risk of acute antibody mediated rejection[J]. Transplantation, 2013, 96(4): 413-420.
|
| 17 |
Doyle TJ, Dellaripa PF. Lungmanifestations of the rheumatic disease[J]. Chest, 2017, 152(6): 1283-1295.
|
| 18 |
Khan IY, Singer LG, de Perrot M, et al. Survival after lung transplantation in systemic sclerosis. A systematic review[J]. Respir Med, 2013, 107(12): 2081-2087.
|
| 19 |
Yazdani A, Sing LG, Strand V, et al. Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation[J]. J Heart Lung Transplant, 2014, 33(5): 514-520.
|
| 20 |
Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies[J]. Int J Cancer, 2009, 125(2): 398-405.
|
| 21 |
Distler O, Pignone A. Pulmonary arterial hypertension and rheumatic disease-from diagnosis to treatment[J]. Rheumatology (Oxford), 2006, 45(Suppl 4): iv22-iv25.
|
| 22 |
Zhang R, Dai LZ, Xie WP, et al. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era[J]. Chest, 2011, 140(2): 302-309.
|
| 23 |
Mathai SC, Hassoun PM. Pulmonary arterial hypertension associated with systemic sclerosis[J]. Expert Rev Respir Med, 2011, 5(2): 267-279.
|
| 24 |
Gottlieb J, Smits J, Schramm R, et al. Lung transplantation in Germany since the introduction of the lung allocation score[J]. Dtsch Arztebl Int, 2017, 114(11): 179-185.
|
| 25 |
Egan TM, Edwards LB. Effect of the lung allocation score on lung transplantation in the United States[J]. J Heart Lung Transplant, 2016, 35(4): 433-439.
|